| Financial Year |
March 31 2023 |
| Monetary Funds |
341,099,435.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,126,864.84 |
| Accounts Receivable |
248,026,340.20 |
| Advances to Suppliers |
18,756,964.17 |
| Other Receivables |
1,014,574.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,634,202.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,731,422.61 |
| Total Current Assets |
812,838,920.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
54,654,268.00 |
| Under-construction Projects |
189,500,635.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,738,753.19 |
| R&D expenses |
-- |
| Goodwill |
37,518,769.89 |
| Long-Term Deferred and Prepaid Expenses |
114,771.95 |
| Deferred Income Tax Assets |
5,540,554.33 |
| Other Non-Current Assets |
4,225,837.64 |
| Sub-Total of Non-Current Assets |
360,071,611.72 |
| Total Assets |
1,172,910,532.57 |
| Short-Term Loans |
5,006,527.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,945,342.60 |
| Accounts Payable |
101,804,979.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,474,109.57 |
| Taxes Payable |
10,880,234.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,595,450.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,437,241.41 |
| Other Current Liabilities |
186,347.39 |
| Sub-Total of Current Liabilities |
188,994,443.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
299,049.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,636,426.00 |
| Total Liabilities |
198,630,869.73 |
| Paid-In Capital(Or Share Stock) |
140,400,000.00 |
| Capital Surplus |
426,637,603.11 |
| Surplus Reserve |
58,905,139.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
348,021,739.91 |
| Minority Stockholder's Interest |
315,180.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
973,964,482.07 |
| Owner's Equity（Stockholder's Equity） |
974,279,662.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,172,910,532.57 |
